Skip to content
MyStudyTimes.com
Provider Reviews

Regenics vs IVIM Health: Pricing, protocol, and trust signals

Rate this post

Regenics vs IVIM Health: quick verdict up front. If you want the lowest promotional entry price and a Sermorelin peptide option, Regenics starts semaglutide at $139 first month and tirzepatide at $189 first month. If you want a structured program with strong third-party ratings and a free consult plus a GIFT75 free-month code, IVIM Health is the option supported by those claims. Both prescribe compounded GLP-1 medications under clinician review and note that compounded drugs are not FDA-approved.

Start Regenics $139 first month

Key differences at a glance for Regenics vs IVIM Health

This comparison focuses on five supported differences: promotional pricing and renewal pricing, clinician model and protocols, third-party validation and trust signals, program features and add-ons, and shipping and membership offers. The sections below directly compare Regenics and IVIM Health using only supplied evidence.

Promotional pricing and ongoing cost

Regenics advertises compounded semaglutide starting at $139 for the first month and tirzepatide starting at $189 for the first month, with sample renewal totals shown as $199 and $279 respectively. Promotional pricing applies to the first month only and renewal prices require reading the fine print. IVIM Health shows lower initial pricing in some materials with $75/mo listed for semaglutide in landing evidence and lists a $99 first month and $174/month ongoing in its FAQ, plus a $74.99/mo program fee noted elsewhere. Both platforms emphasize compounded medication status and clinician review.

Get IVIM free consult and GIFT75

Clinician model and program approach

Regenics is described as nurse-practitioner-led telehealth care where licensed nurse practitioners review intake before anything is prescribed. IVIM Health emphasizes a clinician-guided GLP-1 ID protocol with personalized titration and optimization and offers a no-obligation free consultation for new patients. IVIM’s materials call the GLP-1 ID protocol proprietary and report protocol claims such as up to 40 percent faster weight loss as IVIM’s own claim rather than an independent clinical finding. Both require clinician evaluation and prescribe compounded drugs only when clinically appropriate.

Third-party validation and outcomes claims

IVIM Health reports a 4.9-star rating on both Google and Trustpilot, which the source frames as a rare dual third-party verification and a trust signal. IVIM also cites internal and retrospective observational studies linked to its protocol and notes these are not head-to-head randomized trials. Regenics’ provided evidence highlights LegitScript-certified pharmacy networks and licensed U.S. compounding pharmacy sourcing but does not present the dual third-party rating or the cited protocol studies.

Program features, add-ons, and service details

Regenics includes compounded semaglutide and tirzepatide plus a Sermorelin peptide therapy option and free shipping with medication compounded in the USA. The platform notes FSA/HSA eligibility and that no insurance is required. IVIM emphasizes a program structure with weekly dose adjustments, a program fee noted at $74.99/mo in some captured material, and promotional options including a free month with code GIFT75 and a no-obligation free consultation valued at $75 for new patients. IVIM states its clinical outcomes come from retrospective studies and warns results vary.

Comparison table: Regenics vs IVIM Health

Criteria Regenics IVIM Health
Promotional starting price Semaglutide $139 first month; tirzepatide $189 first month Captured as $75/mo in landing evidence; FAQ lists $99 first month
Ongoing price Examples cited: semaglutide renews $199/mo; tirzepatide $279/mo FAQ lists $174/month ongoing; $74.99/mo program fee noted elsewhere
Clinician model Licensed nurse practitioners review intake before prescription Licensed clinicians guide GLP-1 ID protocol and offer free consult
Third-party validation LegitScript certified pharmacy network noted 4.9-star rating on both Google and Trustpilot reported
Program features Compounded GLP-1 plus Sermorelin peptide; free US shipping Proprietary GLP-1 ID protocol, weekly dose adjustments, free consult
Regulatory note Compounded medications are not FDA-approved finished products Compounded medications are not FDA-approved and not reviewed by FDA

Safety, regulatory, and availability notes

Both sources explicitly state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Regenics notes medications are prepared by U.S. licensed compounding pharmacies and shipped free to your door. IVIM notes compounded medications are prepared by independent licensed compounding pharmacies and that availability is not universal across all states.

Explore Regenics semaglutide and Sermorelin

Which provider is best for different priorities

Choose Regenics if you prioritize a lower promotional first-month price for semaglutide or tirzepatide, want nurse-practitioner-led telehealth care, and value a Sermorelin peptide add-on with free U.S. shipping. Choose IVIM Health if you prioritize verified third-party ratings, a no-obligation free consultation, a structured proprietary GLP-1 ID protocol, and promotional access via code GIFT75. Both require clinician review and prescribe compounded drugs that are not FDA-approved.

Start IVIM free consult and GIFT75

Final note: this comparison used only the supplied evidence for Regenics vs IVIM Health. If details beyond these captured statements are important to you, consult each provider directly and review their full terms, clinical disclosures, and safety information.

Ready to Compare GLP-1, NAD+, TRT Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Leave a comment

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment.